# Ian Peikon

> Ian Peikon is a seed investor at Cajal Neuroscience backing Biotechnology and Pharmaceutical. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Cajal Neuroscience](https://shizune.co/investors/profile/cajal-neuroscience)
- Location: New York, United States
- Total investments: 2
- Last investment: Nov 2022
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/ianpeikon/
- X (Twitter): https://twitter.com/ipeikon
- Website: https://x.com/ipeikon

Ian Peikon is a seed investor at Cajal Neuroscience in New York focused on Biotechnology and Pharmaceutical. Ian is a molecular biologist, engineer, and entrepreneur. He has been involved in the formation and early company building of Lux portfolio companies including Kallyope as well as several other stealth Newcos.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Cajal Neuroscience | Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease. | $96M | Series A | Nov 29, 2022 |  |
| Cajal Neuroscience | Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease. |  | Seed |  |  |

2 of 2 investments shown.

## Co-investors
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund, 1 deal together
- [Bristol-Myers Squibb](https://shizune.co/investors/profile/bristol-myers-squibb) — VC Fund, 1 deal together
- [Dolby Family Ventures](https://shizune.co/investors/profile/dolby-family-ventures) — VC Fund, 1 deal together
- [Evotec](https://shizune.co/investors/profile/evotec-inc) — VC Fund, 1 deal together
- [The Column Group](https://shizune.co/investors/profile/the-column-group) — VC Fund, 1 deal together
- [Two Sigma Ventures](https://shizune.co/investors/profile/two-sigma-ventures) — VC Fund, 1 deal together

## About Cajal Neuroscience

VC Fund · Seattle, United States

Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.

5 contacts available at Cajal Neuroscience.

| Name | Title | Profile |
| --- | --- | --- |
| Ian Peikon | Co-Founder & Chief Scientific Officer | https://shizune.co/investors/profile/ian-peikon |
| Alex Vaughan | Co-Founder | https://shizune.co/investors/profile/alex-vaughn |
| Andrew Dervan | Co-Founder & Chief Operating Officer | https://shizune.co/investors/profile/andrew-dervan-389d |
| Charles Zuker | Co-Founder | https://shizune.co/investors/profile/charles-zuker-f691 |
| Huda Zoghbi | Co-Founder | https://shizune.co/investors/profile/huda-zoghbi |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Ian Peikon invest in?

Ian Peikon invests primarily in Biotechnology and Pharmaceutical startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ian Peikon last invest?

The most recent investment recorded for Ian Peikon closed in Nov 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co